JPS59162883A - Plasmid pmvx group and pmvy group - Google Patents
Plasmid pmvx group and pmvy groupInfo
- Publication number
- JPS59162883A JPS59162883A JP58036619A JP3661983A JPS59162883A JP S59162883 A JPS59162883 A JP S59162883A JP 58036619 A JP58036619 A JP 58036619A JP 3661983 A JP3661983 A JP 3661983A JP S59162883 A JPS59162883 A JP S59162883A
- Authority
- JP
- Japan
- Prior art keywords
- group
- plasmid
- pmvy
- pmvx
- recognition site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、分子量が小さく、遺伝子操作上きわめて有利
なpMVx群及びpMVy群に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to the pMVx group and pMVy group, which have small molecular weights and are extremely advantageous for genetic manipulation.
更に詳細には、本発明は、酢酸菌から分離し、少くとも
1種の制限酵素による認識部位全ただ1ケ所有し、分子
量0.9〜3.6メガダルトンで、遺伝子操作上きわめ
て有利なp MV x群及びpMvy群に関するもので
ある。More specifically, the present invention is directed to an acetic acid bacterium isolated from acetic acid bacteria, which possesses only one recognition site for at least one kind of restriction enzyme, has a molecular weight of 0.9 to 3.6 megadaltons, and is extremely advantageous for genetic manipulation. pMV x group and pMvy group.
従来、酢酸菌由来のプラスミドに関する報告はきわめて
少い。例えば、アセトバクター・アセチ41023が分
子117x10’ダルトン(17メガダルトン)の分子
量のプラスミドをもち、これをpTA5001と命名さ
れたことが報告(Agric BiolChem 46
(2)581−389 、1982)され、また、アセ
トバクター・アセチA1023が分子量17X10’ダ
ルトンの数倍の大きさのプラスミドをもっていることが
報告(日本農芸化学会昭和56年度大会講演要旨集、p
6)され、更に、グルコノバクタ−風細菌タイプカルチ
ャー67株についてプラスミドを検索し、27株にプラ
スミドの存在を認めその分子itは2〜72メガダルト
ンで菌株により複数(最大4ね)のプラスミドをもつも
のがあると報告1酵工学第61巻第1号15−18 、
(1983)されている程度に過ぎない。Until now, there have been very few reports on plasmids derived from acetic acid bacteria. For example, it has been reported that Acetobacter aceti 41023 has a plasmid with a molecular weight of 117 x 10' daltons (17 megadaltons), which was named pTA5001 (Agri BioChem 46
(2) 581-389, 1982), and it was also reported that Acetobacter aceti A1023 has a plasmid with a molecular weight several times the molecular weight of 17 x 10' Daltons (Proceedings of the 1981 Conference of the Japanese Society of Agricultural Chemistry, p.
6) Furthermore, we searched for plasmids in 67 Gluconobacter-like bacterial type culture strains, and found the presence of plasmids in 27 strains.The molecular IT ranged from 2 to 72 megadaltons, and some strains had multiple plasmids (up to 4). Report that there is something 1 Fermentation Engineering Volume 61 No. 1 15-18,
(1983).
本発明者らは、酢酸菌にはよりすぐれたプラスミドが存
在するであろうとの想定のもとに、鋭意研究を行ったと
ころ次の表1VC示される通り11の酢酸菌菌株より数
多くのプラスミドを単離するに至った。The present inventors conducted intensive research based on the assumption that there would be better plasmids in Acetobacter bacteria, and as a result, as shown in Table 1VC below, a large number of plasmids were found from 11 Acetobacter strains. It was isolated.
上表において ta)Fiメガダルトンを示す 2、分子tは、′1気泳動により測定した。In the above table ta) indicates Fi megadaltons 2. Molecule t was measured by '1 pneumophoresis.
3、分子量既知の環状2本鎖DNAの泳動距離をもとに
作成した標準線をもとに寞出した。3. Images were plotted based on a standard line created based on the migration distance of circular double-stranded DNA of known molecular weight.
4、便用したDNAは、ラムダファージDNA、pTA
5001 、バクテリオファージPM2DNA、R8F
’1o1o、 pBR325,pACYC184,pA
CYC177゜pC194である。4. The DNA used was lambda phage DNA, pTA
5001, bacteriophage PM2DNA, R8F
'1o1o, pBR325, pACYC184, pA
CYC177゜pC194.
ここに得られた数多くの酢酵菌由来プラスミドからよシ
有利なプラスミドを求めて更に研究を重ねたところ、遺
伝子操作に有利な分子量が小さく、かつ制限酵素による
認識部位がただ1ケ所であるプラスミド群と呼べるもの
を確立するに至った。After further research in search of a more advantageous plasmid from the numerous plasmids derived from acetic acid ferment bacteria obtained here, we found a plasmid with a small molecular weight that is advantageous for genetic manipulation, and which has only one site recognized by a restriction enzyme. We have now established what can be called a group.
このプラスミド群のなかで、Be o RI又はHi
n d■による認識部位をただ1ケ所有するものをpM
Vx群とした。次の表2においてpMVx群に属するp
Mvio6. pMV201 、 pMV107 O物
理化学性質及び宿主を示す。Among this group of plasmids, Be o RI or Hi
pM is the one that has only one recognition site by n d ■
This was designated as the Vx group. In the following Table 2, p belonging to the pMVx group
Mvio6. pMV201, pMV107O physicochemical properties and hosts are shown.
また、プラスミド群のなかで、AccIによる認m部位
をただ1ケ所有するものをpMVF群とした。Furthermore, among the plasmid groups, those having only one m site recognized by AccI were classified as the pMVF group.
次の表6においてpMVypK属するpMVl 08
。In the following Table 6, pMVypK belongs to pMVl 08
.
pMV202.pMV205.pMV204.pMV2
05.pMV109、pMVllo、pMVill 、
pMVll 5.pPJV114゜pM’V115の物
理化学的性質及び宿主を示す。pMV202. pMV205. pMV204. pMV2
05. pMV109, pMVllo, pMVill,
pMVll5. The physicochemical properties and host of pPJV114°pM'V115 are shown.
上記表2及び表3に示される略記号の意味は次の通シで
ある。The meanings of the abbreviations shown in Tables 2 and 3 above are as follows.
AccI: Ac1netobacter c
alcoaceticus給源の制限酵素
BamHI: Bacillus amyloliq
ue#acie%s H給源の制限酵素
Bst E H: Bacillus stea
rothermophilus ET給源の制限酵素
C1a I : Caryophanon Latu
m L給源の制限酵素
BcoRI: Escherichia coli R
Y13給源の制限酵素
Hind l[: Haemophilus 1nfl
uer+zae Rd給源の制限酵素
Pst I : Providencia 5tua
rtii給源の制限酵素
5ali: 8treptomyces albu
s G給源の制限酵素
本発明のプラスミドpMVx群及びpMVy群のプラス
ミドに従来報告された例はなく、すべて新規プラスミド
であり、かつ、本シラスミド群は分子量が0.9〜3.
6メガダルトンときわめて小さく、そのtn製はきわめ
て容易であり、その上に少くとも1柚の制限酵素による
認識部位をただ1ケ所有しているためキメラプラスミド
ヲ裏作するのに好適であるなど、遺伝子操作上有益なプ
ラスミド群ということができる。AccI: Ac1netobacter c
Restriction enzyme BamHI from B. alcoaceticus source: Bacillus amyloliq
ue#acie%s H source restriction enzyme Bst E H: Bacillus stea
lothermophilus ET source restriction enzyme C1a I: Caryophanon Latu
ml Source of restriction enzyme BcoRI: Escherichia coli R
Y13 source restriction enzyme Hindl[: Haemophilus 1nfl
uer+zae Rd source restriction enzyme Pst I: Providencia 5tua
Restriction enzyme 5ali from rtii source: 8treptomyces albu
s G source restriction enzyme There are no previously reported examples of the plasmids of the pMVx group and pMVy group of the present invention, and all of them are new plasmids, and the present cilasmid group has a molecular weight of 0.9 to 3.
It is extremely small at 6 megadaltons, making it extremely easy to make tn, and it is suitable for producing chimeric plasmids because it has only one recognition site for at least one restriction enzyme. It can be said that this is a group of plasmids that are useful for genetic manipulation.
次に本発明の実施例を示す。Next, examples of the present invention will be shown.
実癩例1
(プラスミドの分離精製法)
アセトバクター・バスツリアヌスIF’03223を5
dのA培地〔2%グリセロール、0.2%塩化アンモニ
ウム、0.05%リン酸1カリウム、0.05チリン酸
2カリウム、0.02%硫酸マグネシウム。Leprosy example 1 (Plasmid isolation and purification method) Acetobacter basturianus IF'03223 5
d A medium [2% glycerol, 0.2% ammonium chloride, 0.05% monopotassium phosphate, 0.05 dipotassium typhosphate, 0.02% magnesium sulfate.
0.2%酵母エキス、0.2%ポリペプトン、 pH6
,5〕に植菌し、30℃で24時時間上り培養した。そ
の後、新しいA培地5ooyvc11で植え継ぎをし、
60℃で36時間振とう培34]〜た。集菌後、20
m M(1) EDTA k含む50 m M )リス
塩酸緩衝液(P)(B、0)で2回菌体を洗浄した。得
られた湿菌体2gあ7’C97mlのTE8緩衝液(5
0mM)リス塩酸、20 m M EDTA、25%シ
ョ糖、pH8,0’)を加え、菌体ft@濁し、411
Llのリゾチーム液(0,25Mトリス塩酸、リゾチー
ム20〜、pH8,0)fさらに加え、0℃で5分装置
した。次に0.25MEDTA液(pH8,0)を4d
加え、0℃で5分装置した後、37℃で20分間反応さ
せた。反応後、311Llの10チラウリル硫酸ナトリ
ウムを加え、67℃で20分間靜置後、5Nの5M食塩
水を加え、0℃で一夜静置した。48,200gで60
分間遠心分離をかけ、上清を分取した。次にこの上清に
最終濃度で10チになるようにポリエチレングリコール
6、ODDを加え、4℃で一夜静置した後、3.000
gで10分間遠心分離し、沈澱物を得た。0.2% yeast extract, 0.2% polypeptone, pH6
, 5] and cultured at 30°C for 24 hours. After that, subplant with new A medium 5ooyvc11,
The culture was shaken at 60°C for 36 hours [34]. After collecting bacteria, 20
The bacterial cells were washed twice with 50 m m ) Lis-HCl buffer (P) (B, 0) containing m M (1) EDTAk. 2 g of the obtained wet bacterial cells was mixed with 97 ml of TE8 buffer (5
411
A lysozyme solution (0.25M Tris-HCl, lysozyme 20~, pH 8.0) of Ll was further added, and the mixture was incubated at 0°C for 5 minutes. Next, add 4 d of 0.25 MEDTA solution (pH 8,0).
After addition, the mixture was incubated at 0°C for 5 minutes, and then reacted at 37°C for 20 minutes. After the reaction, 311 Ll of 10 sodium thirauryl sulfate was added, and after standing at 67°C for 20 minutes, 5N 5M saline was added, and the mixture was left standing at 0°C overnight. 60 for 48,200g
Centrifugation was performed for a minute, and the supernatant was collected. Next, polyethylene glycol 6 and ODD were added to this supernatant to a final concentration of 10%, and after standing at 4°C overnight,
The mixture was centrifuged at g for 10 minutes to obtain a precipitate.
、この沈澱物を7mlのUC緩衝液(50mM)リス塩
酸、5 mMEDTA、 50 mM NaCl、 p
H7,8)に溶解させた後、最終濃度で500μg/プ
になるようにエチジウムブロマイドを加え、さらに塩化
セシウムを加えて密度を1.57に合わせた。この溶Q
fc15℃、100.200 gで40時間密度勾配遠
心分離をおこなった。遠心分離後、遠心チューブに紫外
線ランプで365 nmの紫外−を照射することにより
、染色体バンドの下にあられれるバンドをプラスミド分
画として分取した。次いで、分画液をインプロパツール
で処理し、エチジウムブロマイド全除去した後、TE緩
衝液(10mMトリス塩酸、1 m M EDTA、
pti 7.5 )に対して透析した。アセトバクター
・バスツリアヌスIFO6226け、分子量のことなる
8つのシラスミドをもっており、透析後プラスミド分画
液を垂直型0.8チアガロースゲル電気泳動に供し、ゲ
ルを1翔/ツのエチジウムブロマイドに浸し染色した後
、紫外線照射下で相当するプラスミドバンドをゲルごと
分取して、他のプラスミドから単離した。分取したゲル
にゲルの重量の6倍量の過塩素酸ナトリ7ム溶液(6M
過塩素酸ナトリウム、25mMリン酸2ナトリウム、2
5mMリン酸1ナトリウム、10 mM BDTA、
pH70) ”c加え、67℃で1時間静置し、アガロ
ースを溶解させた後、ワットマ/a[MGpcフィルタ
ーにDNA tl−吸着させた。, this precipitate was mixed with 7 ml of UC buffer (50 mM) Lis-HCl, 5 mM EDTA, 50 mM NaCl, p
After dissolving in H7,8), ethidium bromide was added to give a final concentration of 500 μg/p, and cesium chloride was further added to adjust the density to 1.57. This melt Q
Density gradient centrifugation was performed at fc15° C. and 100.200 g for 40 hours. After centrifugation, the centrifuge tube was irradiated with 365 nm ultraviolet light using an ultraviolet lamp, and the band that appeared below the chromosome band was separated as a plasmid fraction. Next, the fractionated solution was treated with Impropatool to completely remove ethidium bromide, and then treated with TE buffer (10mM Tris-HCl, 1mM EDTA,
Pti 7.5). Acetobacter basturianus IFO6226 has eight cilasmids with different molecular weights. After dialysis, the plasmid fraction was subjected to vertical 0.8 thiagarose gel electrophoresis, and the gel was stained by soaking it in ethidium bromide at 1 kg/kg. Thereafter, the corresponding plasmid band was fractionated on the gel under ultraviolet irradiation and isolated from other plasmids. Add 7M sodium perchlorate solution (6M) to the separated gel in an amount 6 times the weight of the gel.
Sodium perchlorate, 25mM disodium phosphate, 2
5mM monosodium phosphate, 10mM BDTA,
pH 70) was added, and the mixture was allowed to stand at 67°C for 1 hour to dissolve the agarose, and then DNA tl-adsorbed onto a Whatma/a [MGpc filter].
吸着させたDNAをTE緩衝液で溶出させ、この溶出液
100μlに200μlの995%エタノールを加え、
−80℃に2時間おいた後、15.[100gで5分間
遠心分離をおこないDNAを沈降させ、さらに真空乾燥
をおこなってプラスミドpvvio6を得た。The adsorbed DNA was eluted with TE buffer, and 200 μl of 995% ethanol was added to 100 μl of this eluate.
After leaving at -80℃ for 2 hours, 15. [The DNA was centrifuged at 100 g for 5 minutes to precipitate the DNA, which was further vacuum-dried to obtain plasmid pvvio6.
(各種制限酵素による切断特異性および分子量測定法)
前記で調製したプラスミドをTE緩衝液に溶解し、少な
くとも5倍量過剰の制限酵素(AccI。(Cleavage specificity and molecular weight measurement method using various restriction enzymes) The plasmid prepared above was dissolved in TE buffer, and the restriction enzyme (AccI) was added in excess of at least 5 times.
BamHI 、 )lind * 、 Psi Iおよ
び8al Iは宝酒造社製、BstEII、C1aXI
tlベーリンガー・マンハイム社製、BcoR4は、ベ
セスダ・・リサーチ社製全使用した。)を各々の制限酵
素の至適条件下で反応させた。反応後、垂直型アガロー
スゲル電気泳動で分析した。即ち、1%アガロースゲル
を用い、トリス酢酸緩衝液(40mMトリス、20mM
酢酸、2 m M BDTA、 pH8,1)中で泳動
させた。その後、ゲルをエチジウムブロマイドの1μg
/mA’液に浸して染色した。このゲルに紫外線全照射
【−1生成断片の数を判定し、各断片の泳動距離から、
各々の分子量を算出した。分子tFi、、同一アガロー
ス上で同時に泳動したラムダ7アージDNAのHind
u切断で生成する分子量既知の各断片の泳動距離から作
成した標準線をもとに算出した。BamHI, )lind*, Psi I and 8al I are manufactured by Takara Shuzo Co., Ltd., BstEII, C1aXI
tl Boehringer Mannheim, BcoR4, Bethesda Research, were all used. ) were reacted under optimal conditions for each restriction enzyme. After the reaction, it was analyzed by vertical agarose gel electrophoresis. That is, using a 1% agarose gel, Tris acetate buffer (40mM Tris, 20mM
The gel was run in acetic acid, 2mM BDTA, pH 8,1). The gel was then washed with 1 μg of ethidium bromide.
/mA' solution for staining. This gel was irradiated with UV light [-1] to determine the number of generated fragments, and from the migration distance of each fragment,
The molecular weight of each was calculated. Molecular tFi, Hind of lambda 7age DNA run simultaneously on the same agarose.
It was calculated based on a standard line created from the migration distance of each fragment of known molecular weight produced by u-cleavage.
実施例2
グルコノバクタ−・スフレロイテラスIAM1842か
らのプラスミドの分離精製は、培養時の培地をG培地(
2%グルコン酸、0.5チグルコース、0.5チグリセ
ロール、0.2チ酵母エキス、0.2チボリベプト/、
piis、5)とし、新しい培地の液量を20[1mJ
、培養時間′fr:24時間と変化させた以外は実施例
1に準じて行ない、精製シラスミドpMv201 i得
た。制限酵素による特異的切断および分子量測定も実施
例1に準じて行なつfc。Example 2 Isolation and purification of plasmid from Gluconobacter souffleleutelas IAM1842 was performed using G medium (
2% gluconic acid, 0.5 Tiglucose, 0.5 Tiglycerol, 0.2 Ti yeast extract, 0.2 Tivorivept/,
piis, 5), and the volume of new medium was 20 [1 mJ
Purified cilasmid pMv201i was obtained in the same manner as in Example 1, except that the culture time 'fr was changed to 24 hours. Specific cleavage with restriction enzymes and molecular weight measurement were also carried out according to Example 1.
代理人 弁理士 戸 1)親 男Agent Patent Attorney 1) Parent Male
Claims (1)
識部位をただ1ケ所有し、かつ、分子量が0.9〜6.
6メガダルトンであるプラスミドp M V x群及び
pMvy群ゎ (21gcoRI又FiHi n d lによる認識部
位をただ1ケ所有する特許請求の範囲第1項記載のプラ
スミ ド p MV x 群。 (31pMV106、pMV201及びpMV107か
らなる特許請求の範囲第1項記載のプラスミドp M
Vx肝。 (4) A c c Iによる認識部位をただ1ケ所
有する特許請求の範囲第1項記載のプラスミドpMvy
IR,。 (51pMV108、pMV202、pMV203.p
MV204、pMV205、pMVID9、pMVl
10、pMVI 11、PMV115、pMVl 14
、及びpMVl 15からなる特許請求の範囲第1項記
載のプラスミドpMVy群。[Scope of Claims] (1) It is derived from acetic acid bacteria, has only one recognition site for at least one restriction enzyme, and has a molecular weight of 0.9 to 6.
6 megadalton plasmids pMV x group and pMvy group (21gcoRI or FiHin dl recognition site) plasmid pMV x group according to claim 1. (31pMV106, Plasmid pM according to claim 1 consisting of pMV201 and pMV107
Vx liver. (4) Plasmid pMvy according to claim 1, which has only one A c c I recognition site
IR,. (51pMV108, pMV202, pMV203.p
MV204, pMV205, pMVID9, pMVl
10, pMVI 11, PMV115, pMVl 14
The plasmid pMVy group according to claim 1, consisting of , and pMVl 15.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58036619A JPS59162883A (en) | 1983-03-08 | 1983-03-08 | Plasmid pmvx group and pmvy group |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58036619A JPS59162883A (en) | 1983-03-08 | 1983-03-08 | Plasmid pmvx group and pmvy group |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59162883A true JPS59162883A (en) | 1984-09-13 |
JPH0322154B2 JPH0322154B2 (en) | 1991-03-26 |
Family
ID=12474814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58036619A Granted JPS59162883A (en) | 1983-03-08 | 1983-03-08 | Plasmid pmvx group and pmvy group |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59162883A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127174A (en) * | 1998-08-11 | 2000-10-03 | Ajinomoto Co., Inc. | Plasmid derived from gluconobacter bacteria and vector |
-
1983
- 1983-03-08 JP JP58036619A patent/JPS59162883A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127174A (en) * | 1998-08-11 | 2000-10-03 | Ajinomoto Co., Inc. | Plasmid derived from gluconobacter bacteria and vector |
Also Published As
Publication number | Publication date |
---|---|
JPH0322154B2 (en) | 1991-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI64813B (en) | FOERFARANDE FOER PRODUCERING AV ETT UTVALT AEGGVITEAEMNE OCH VID FOERFARANDET ANVAENDA REKOMBINANTPLASMIDVEKTORER | |
JPH0838176A (en) | Improved recombination dna molecule | |
JPS63503032A (en) | Methods and means for producing immunoglobulin binding proteins | |
JPH0755153B2 (en) | Recombinant DNA molecule and method for producing the same | |
JPS59162883A (en) | Plasmid pmvx group and pmvy group | |
JPS62122589A (en) | Dna base sequence and vector | |
JPH0363356B2 (en) | ||
JP2561674B2 (en) | Method of producing protein | |
McCorquodale et al. | Gene D5 product of bacteriophage T5: DNA-binding protein affecting DNA replication and late gene expression | |
US5049501A (en) | Production method for PvuI restriction endonuclease | |
JPS59203495A (en) | Novel method for developing exogenote | |
JP2518051B2 (en) | Method for producing AccI restricted endonuclease | |
JPH02286077A (en) | Bacillus-s-p, dna fragment containing l-lactic acid dehydrogenase gene, gene recombinant plasmid containing the same gene, l-lactic acid dehydrogenase gene and gene recombinant plasmid containing the same gene | |
SU1523054A3 (en) | Method of producing human w-interferon | |
US4721671A (en) | Efficient prokaryotic expression system using portions of the E. coli .beta. | |
Yeung et al. | Construction of miniplasmids from the 7.2-kb and 5.1-kb penicillinase-producing plasmids of Neisseria gonorrhoeae reveals two replication regions | |
JP2833793B2 (en) | Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase | |
EP0234075A1 (en) | Prokaryotic expression system | |
JPS63157983A (en) | Method for producing thermostable β-isopropylmalate dehydrogenase | |
JPS6368087A (en) | DNA containing regions involved in protein expression and secretion | |
RU1445193C (en) | Recombinant plasmid dna pga 23 | |
JPH0665301B2 (en) | Method for producing NAL (N-acylneuraminic acid aldolase) | |
JPH01502478A (en) | Recombinant plasmid DNA pPR-IFNβ1-13 encoding the synthesis of human β1-interferon in fibroblast cells, its manipulation method, and E. coli containing the same plasmid DNA and producing human β1-interferon | |
JPH03112484A (en) | Novel restriction enzyme and its production | |
JPH0371115B2 (en) |